Pathological Myopia
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases (NCT03128463) | Xun Xu | 2017-02-28 |
| Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia (NCT01217944) | Novartis Pharmaceuticals | 2010-10-01 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (NCT00470977) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
| Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) (NCT00407719) | Johns Hopkins University | 2005-06-01 |
Track Pathological Myopia automatically
Every clearance here is in the API, with alerts when new ones post.